Oliver Lagore Vanvalin Investment Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$4.16K Sell
1,100
-500
-31% -$1.89K ﹤0.01% 528
2024
Q3
$5.18K Buy
+1,600
New +$5.18K ﹤0.01% 502